BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 942890)

  • 1. Calcitonin in breast and lung cancer.
    Hillyard CJ; Coombes RC; Greenberg PB; Galante LS; MacIntyre I
    Clin Endocrinol (Oxf); 1976 Jan; 5(1):1-8. PubMed ID: 942890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immuno-heterogeneity of the calcitonins of hypercalcemia, breast and lung cancers and medullary carcinoma of thyroid.
    Roof BS; Weinstein R; Vujic I; Burdash NM
    Biomedicine; 1979 Jun; 30(2):82-90. PubMed ID: 476268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ectopic secretion of calcitonin by lung and breast carcinomas.
    Coombes RC; Ellison ML; Easty GC; Hillyard CJ; James R; Galante L; Girgis S; Heywood L; MacIntyre I; Neville AM
    Clin Endocrinol (Oxf); 1976; 5 Suppl():387S-396S. PubMed ID: 1053252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medullary carcinoma of the thyroid gland. Studies of thyrocalcitonin in plasma and tumor extracts.
    Tashjian AH; Melvin EW
    N Engl J Med; 1968 Aug; 279(6):279-83. PubMed ID: 5660301
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum levels and biochemical characteristics of cancer-associated antigen CA-549, a circulating breast cancer marker.
    Bray KR; Koda JE; Gaur PK
    Cancer Res; 1987 Nov; 47(22):5853-60. PubMed ID: 2444335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity of immunoreactive calcitonin in extracts of medullary thyroid carcinoma.
    Rude RK; Matsumoto S; Singer FR
    Miner Electrolyte Metab; 1982 Jun; 7(6):292-7. PubMed ID: 6302462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoreactive calcitonin in non-thyroid tumours.
    Hillyard CJ; Coombes RC; Greenberg PB; MacIntyre I
    Calcif Tissue Res; 1976 Aug; 21 Suppl():304-9. PubMed ID: 953818
    [No Abstract]   [Full Text] [Related]  

  • 8. A preliminary evaluation of calcitonin and PDN-21 as tumor markers for lung cancer. EORTC Lung Cancer Working Party.
    Body JJ; Dumon JC; Sculier JP; Dabouis G; Lacroix H; Libert P; Richez M; Bureau G; Mommen P; Raymakers N
    Henry Ford Hosp Med J; 1989; 37(3-4):190-3. PubMed ID: 2639133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The biological and clinical significance of tumor markers in tissue extracts.
    Castelli M; Sega FM; Sciarretta F; Casale V; Coloni F; Sega E
    Cancer Detect Prev; 1983; 6(1-2):61-6. PubMed ID: 6883394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ectopic ACTH production in carcinoma of the lung.
    Gewirtz G; Yalow RS
    J Clin Invest; 1974 Apr; 53(4):1022-32. PubMed ID: 4360854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Present status of calcitonin research with special attention to conditions in man].
    Sorensen OH; Hindberg I
    Ugeskr Laeger; 1970 Feb; 132(9):426-9. PubMed ID: 4914424
    [No Abstract]   [Full Text] [Related]  

  • 12. Calcitonin, calcitonin gene-related peptide, and gastrin-releasing peptide in familial thyroid medullary carcinoma.
    Månsson B; Ahrén B; Nobin A; Böttcher G; Sundler F
    Surgery; 1990 Feb; 107(2):182-6. PubMed ID: 2300897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma-immunoreactive-calcitonin in patients with non-thyroid tumours.
    Coombes RC; Hillyard C; Greenberg PB; MacIntyre I
    Lancet; 1974 Jun; 1(7866):1080-3. PubMed ID: 4135248
    [No Abstract]   [Full Text] [Related]  

  • 14. [Heterogeneity of immunoreactive calcitonin in the plasma of patients with bone marrow cancer].
    Moukhtar MS; Jullienne A; Taboulet J; Calmettes C; Raulais D; Milhaud G
    Pathol Biol (Paris); 1975 Dec; 23(10):809-14. PubMed ID: 772524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcitonin in nonthyroidal cancer.
    Schwartz KE; Wolfsen AR; Forster B; Odell WD
    J Clin Endocrinol Metab; 1979 Sep; 49(3):438-44. PubMed ID: 468977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of a breast tissue-associated antigen by antiserum to Raji cell-bound circulating immune complexes of human breast cancer.
    Koestler TP; Papsidero LD; Nemoto T; Chu TM
    Cancer Res; 1981 Jul; 41(7):2900-7. PubMed ID: 7018673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measuring calcitonin.
    Lancet; 1983 Mar; 1(8324):585. PubMed ID: 6131273
    [No Abstract]   [Full Text] [Related]  

  • 18. Identification and measurement of calcitonin precursors in serum of patients with malignant diseases.
    Ghillani PP; Motté P; Troalen F; Jullienne A; Gardet P; Le Chevalier T; Rougier P; Schlumberger M; Bohuon C; Bellet D
    Cancer Res; 1989 Dec; 49(23):6845-51. PubMed ID: 2555054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Determination of calcitonin and parathyrin in blood serum in the diagnosis of tumor metastases to bone].
    Smirnov IuN
    Med Radiol (Mosk); 1986 Apr; 31(4):9-12. PubMed ID: 3959820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The localization of human keratin proteins at cytological and histological levels in carcinomatous and sarcomatous lesions.
    Yagi Y; Imamura Y; Saku T; Shimotsu T; Hatae M; Yagi S
    Jpn J Clin Oncol; 1986 Mar; 16(1):9-19. PubMed ID: 2422410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.